Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
54 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • Cannabis
  • FDA
  • General
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested

By Fermin Orgambide
Today, 6:55 PM
On Wednesday, May 18, Clearmind Medicine Inc. (OTC Pink: CMNDF) will meet with the Center for Drug Evaluation and Research (CDER), a department within the FDA.

CMNDF

Read More
1 minute read
  • Cannabis
  • General
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Irwin Naturals And Assurance Laboratories Reach Licensing Agreement For THC Products In New Mexico

By Fermin Orgambide
Today, 6:55 PM
After inking a deal with The Hive Laboratory last month, Irwin Naturals Inc.

IWINF

Read More
1 minute read
  • Cannabis
  • General
  • Health Care
  • Markets
  • News
  • Psychedelics

Veterans In Arizona Will Have Access To Ketamine Therapy At No Out-Of-Pocket Cost

By Fermin Orgambide
Today, 6:55 PM
Delic Holdings Corp’s (OTCQB: DELCF) Ketamine Wellness Center will provide military veterans in Arizona with ketamine therapy for treatment-resistant depression (TRD) and PTSD.

DELCF

Read More
2 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Psychedelics

Can LSD Treat Anxiety? MindMed’s New Topline Data Show Promise, Here’s The Research

By Fermin Orgambide
Today, 6:55 PM
MindMed (NASDAQ: MNMD) researchers shared topline clinical results for a Phase 2 LSD clinical study at the recent Psych Symposium, which was co-sponsored by University Hospital Basel (UHB).

MNMD

Read More
2 minute read
  • Biotech
  • Cannabis
  • General
  • M&A
  • Markets
  • News
  • Psychedelics
  • Small Cap

Novamind And Numinus Prepare For Acquisition, Both Companies Share Info Circulars To Shareholders

By Fermin Orgambide
Today, 6:55 PM
June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF).

BNOX

Read More
1 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Psychedelics
  • Topics

Pilot Study By Cybin Shows That Ketamine Modifies Connectivity Between Brain Regions

By Fermin Orgambide
Today, 6:55 PM
Cybin Inc. (NYSE:CYBN) and Kernel, two companies that undertook a joint feasibility study to evaluate the effects ketamine has on blood flow in the brain in late March,&nbs

CYBN

Read More
1 minute read
  • Cannabis
  • Markets
  • News

Nugl TV Extends Contract With Rap Heavy Players Arnold Bigg A White And Lil Eazy-E

By Fermin Orgambide
Today, 6:55 PM
Cannabis-focused multimedia platform Nugl (OTC:NUGL) announced that Rich and Rutless’ Arnold “Bigg A” White and Lil Eazy-E, Eazy-E’s son, extended their contracts with the company.

NUGL

Read More
1 minute read
  • Cannabis
  • General
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Pharmather Lands US Patent To Formulate, Produce Ketamine With This New Process

By Fermin Orgambide
Today, 6:55 PM
The U.S. Patent and Trademark Office has granted Pharmather Holdings Ltd. (OTCQB: PHRRF) a patent for a ketamine production process.

PHRRF

Read More
1 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

What Is NAD+, Ketamine Wellness Center’s New Therapy?

By Fermin Orgambide
Today, 6:55 PM
Delic Holdings Corp.’s (OTCQB: DELCF) subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy.

DELCF

Read More
1 minute read
  • Biotech
  • Cannabis
  • General
  • Markets
  • News
  • Psychedelics

FSD Pharma Enters Agreement With Tekkfund Capital Corp To Develop Business

By Fermin Orgambide
Today, 6:55 PM
FSD Pharma Inc. (NASDAQ: HUGE) entered into an agreement with Tekkfund Capital Corp to structure and assist “with certain business development strategies.”

HUGE

Posts navigation

Previous 1 2 3 … 6 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service